Information about VELCADE and diseases we focus on.
Information about VELCADE and related topics.
The company and its commitment to develop breakthrough treatments for cancer and inflammatory diseases.
Information about
VELCADE
®
(bortezomib) for Injection.
Our development pipeline and research in cancer and inflammation.
Recent news and general information about the company and its management.
Searchable job database, benefits information, employees' insights, and calendar of recruiting events.
Takeda to Acquire Millennium for US$25.00 Per Share
More
Millennium Announces VELCADE
®
Q1 2008 U.S. Net Sales...
More
© 2008 Millennium Pharmaceuticals, Inc.
Update Notice
|
Usage Terms
|
Privacy Policy